These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1833241)

  • 1. Substrate antagonism in the kinetic mechanism of E. coli phosphofructokinase-1.
    Deville-Bonne D; Laine R; Garel JR
    FEBS Lett; 1991 Sep; 290(1-2):173-6. PubMed ID: 1833241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction path of phosphofructo-1-kinase is altered by mutagenesis and alternative substrates.
    Wang X; Kemp RG
    Biochemistry; 2001 Apr; 40(13):3938-42. PubMed ID: 11300773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible high hydrostatic pressure inactivation of phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Else AJ
    Eur J Biochem; 1991 Sep; 200(3):747-50. PubMed ID: 1833191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-site mutants altering the cooperativity of E. coli phosphofructokinase.
    Berger SA; Evans PR
    Nature; 1990 Feb; 343(6258):575-6. PubMed ID: 2137204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characteristics of phosphofructokinase from Bacillus stearothermophilus: MgATP nonallosterically inhibits the enzyme.
    Byrnes M; Zhu X; Younathan ES; Chang SH
    Biochemistry; 1994 Mar; 33(11):3424-31. PubMed ID: 8136379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crystal complex of phosphofructokinase-2 of Escherichia coli with fructose-6-phosphate: kinetic and structural analysis of the allosteric ATP inhibition.
    Cabrera R; Baez M; Pereira HM; Caniuguir A; Garratt RC; Babul J
    J Biol Chem; 2011 Feb; 286(7):5774-83. PubMed ID: 21147773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose 2,6-bisphosphate and AMP increase the affinity of the Ascaris suum phosphofructokinase for fructose 6-phosphate in a process separate from the relief of ATP inhibition.
    Payne MA; Rao GS; Harris BG; Cook PF
    J Biol Chem; 1991 May; 266(14):8891-6. PubMed ID: 1827438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced conformational transitions in Escherichia coli phosphofructokinase 2: evidence for an allosteric site for MgATP2-.
    Guixé V; Rodríguez PH; Babul J
    Biochemistry; 1998 Sep; 37(38):13269-75. PubMed ID: 9748334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction mechanism of non-allosteric phosphofructokinase.
    Simon WA; Hofer HW
    Eur J Biochem; 1978 Jul; 88(1):175-81. PubMed ID: 149659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of muscle phosphofructokinase at physiological concentration of enzyme.
    Boscá L; Aragón JJ; Sols A
    J Biol Chem; 1985 Feb; 260(4):2100-7. PubMed ID: 2982809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-steady state quantification of the allosteric influence of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    J Biol Chem; 2001 Sep; 276(37):34388-95. PubMed ID: 11443117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of rabbit muscle phosphofructokinase at pH8.
    Merry S; Britton HG
    Biochem J; 1985 Feb; 226(1):13-28. PubMed ID: 3156586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MgATP and fructose 6-phosphate interactions with phosphofructokinase from Escherichia coli.
    Johnson JL; Reinhart GD
    Biochemistry; 1992 Nov; 31(46):11510-8. PubMed ID: 1445885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphofructokinase from baker's yeast: kinetic properties of a proteolytically modified enzyme.
    Bär J; Schellenberger W; Kopperschläger G
    Biomed Biochim Acta; 1989; 48(7):387-92. PubMed ID: 2529853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit muscle phosphofructokinase. The kinetic mechanism of action and the equilibrium constant.
    Hanson RL; Rudolph FB; Lardy HA
    J Biol Chem; 1973 Nov; 248(22):7852-9. PubMed ID: 4270771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.